Articles tagged "Infection"

2022 American Transplant Congress
Accepting Rejection in Liver Transplant Recipients Requiring Renal Replacement Therapy: A Practice Paradigm
S. Farghaly¹, T. Sparkes¹, B. Masters¹, A. Haririan², N. Jakhete³, R. N. Barth⁴, D. Maluf⁵, S. Freedman¹
¹Pharmacy, University of Maryland Medical Center, Baltimore, MD, ²Nephrology, University of Maryland Medical Center, Baltimore, MD, ³Hepatology, University of Maryland Medical Center, Baltimore, MD, ⁴Transplant Surgery, University of Chicago Medical Center, Chicago, IL, ⁵Transplant Surgery, University of Maryland Medical Center, Baltimore, MD
*Purpose: The purpose of this study is to evaluate rejection outcomes in those requiring renal replacement therapy (RRT) after liver transplant.*Methods: This was a single…
2022 American Transplant Congress
Comparison of Cephalexin and Ciprofloxacin Prophylaxis for Urinary Tract Infection in Kidney Transplant Recipients
N. A. Pauley, M. Fitzmaurice, A. Poparad-Stezar, B. Summers, A. Jantz
Transplant Institute, Henry Ford Hospital, Detroit, MI
*Purpose: Compare efficacy and safety outcomes of patients (pts) that received alternative agents as prophylaxis (ppx) for urinary tract infection (UTI) after kidney transplant (KT)…
2022 American Transplant Congress
Lack of Measles Immunity and Vaccination Rates in Patients Being Evaluated for Solid Organ Transplant: Missed Opportunities
C. Larsen¹, C. Kotton²
¹Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, ²Massachusetts General Hospital, Boston, MA
*Purpose: Solid organ transplant (SOT) recipients are not eligible for live-vaccines, including the measles, mumps and rubella (MMR) vaccine, due to safety concerns on immunosuppression.…
2022 American Transplant Congress
Outcomes in Lung Transplant Recipients Switched from Tacrolimus to Cyclosporine Due to Hyperammonemia Early Post-Transplantation
S. Goyal, J. Lyons, P. Stracener, B. Bemiss
Loyola University Medical Center, Chicago, IL
*Purpose: Assess the impact of switching from tacrolimus to cyclosporine due to hyperammonemia on outcomes at 1-year post-lung transplant.*Methods: A retrospective review of lung transplant…
2022 American Transplant Congress
Preemptive Therapy in Cytomegalovirus (CMV) Seropositive Donor to Seronegative Recipient Liver Transplants
J. Revollo, E. Aldag, K. Cooper, B. Noell, V. Casingal, K. Gajurel
Transplant, Atrium Health's Carolinas Medical Center, Charlotte, NC
*Purpose: To evaluate if a preemptive therapy strategy can prevent CMV disease and induce CMV seroconversion.*Methods: Observational data collection for CMV D+/R- adult liver transplant…
2022 American Transplant Congress
Infections Requiring Hospitalization After Simultaneous Pancreas-Kidney Transplantation Compared to Kidney Transplantation Alone
J. Grasberger¹, F. Ortiz², A. Ekstrand², V. Sallinen¹, M. Lempinen¹, I. Helanterä¹
¹Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland, ²Nephrology, Helsinki University Hospital, Helsinki, Finland
*Purpose: Although infections related to surgical complications are more common after simultaneous pancreas-kidney transplantation (SPK) compared to kidney transplantation alone (KTA), the burden of infections…
2022 American Transplant Congress
Organs from Donors with Positive SARS-CoV-2 NAT+ Testing: A Report from the Ad Hoc Disease Transmission Advisory Committee
L. Danziger-Isakov¹, J. D. Goldman¹, A. Wooley¹, S. Pouch¹, A. Agarwal¹, G. Berry¹, K. Dunn¹, S. Ho¹, M. Kittleson¹, D. H. Lee¹, D. Levine¹, C. Marboe¹, G. Marklin¹, R. Razonable¹, S. Taimur¹, H. Te¹, C. Fox², C. Jett², S. Booker², D. Klassen², R. LaHoz¹
¹OPTN, Richmond, VA, ²UNOS, Richmond, VA
*Purpose: Decision to transplant organs from SARS-CoV-2 NAT+ donors(N+D) balances risk of donor-derived infection with the scarcity of available organs to meet the needs of…
2022 American Transplant Congress
HLA Alleles Add to Risk Stratification for CMV Infection in Renal Transplant Recipients
R. Patil¹, R. Prashar², M. Ramesh², A. Patel²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Transplant Institute, Detroit, MI
*Purpose: Cytomegalovirus (CMV) is the most common viral infection that occurs after solid organ transplantation. The incidence of CMV infection or disease (I/d) varies based…
2022 American Transplant Congress
Early versus Delayed Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Hutchins¹, M. Leick², M. Keck², J. S. McMullen²
¹Pharmacy, Houston Methodist Hospital, Houston, TX, ²Pharmacy, Nebraska Medicine, Omaha, NE
*Purpose: The purpose of this study is to determine the effect of delaying cytomegalovirus (CMV) prophylaxis to day of discharge or post-operative day (POD) 7…
2022 American Transplant Congress
Infectious Disease Testing Among US Deceased Organ Donors
A. Mezochow¹, T. Bittermann¹, E. Blumberg¹, R. Hasz², J. Anesi¹
¹Hospital of the University of Pennsylvania, Philadelphia, PA, ²Gift of Life Donor Program, Philadelphia, PA
*Purpose: Donor-derived infections are associated with significant morbidity in solid organ transplant recipients. To reduce the risk of donor-derived infections, the United Network for Organ…